Klinischer Stellenwert bildgebender Verfahren im ersten Jahr nach brusterhaltender Therapie des Mammakarzinoms

Zusammenfassung

Ziel: Vergleich der bildgebenden Verfahren Mammographie (MX), Ultraschall (US) und MR-Mammographie (MRT) im ersten Jahr nach brusterhaltender Therapie bei Mammakarzinom. Methode: 20 Patientinnen wurden vor adjuvanter Radiotherapie sowie drei, sechs und zwölf Monate danach mit den drei Verfahren untersucht. Alle 220 Untersuchungen wurden von zwei Beobachtern retrospektiv, randomisiert und verblindet im Hinblick auf Läsionsdetektion und -charakterisierung ausgewertet. Ferner erfolgte die Bestimmung von κ-Werten als Maß für die Übereinstimmung der Ergebnisse bei verschiedenen Untersuchern, Methoden und Zeitpunkten. Ergebnisse: Als sicher ohne Läsion qualifizierten die Untersucher bei der MRT 43 % der beurteilten Mammae, bei der MX 30 % und beim US 5 % (p < 0,05). Richtig negative Befunde erzielte die MRT bei 94,4 % gegenüber 90,4 % bei der MX und 82,5 % beim US. Die Übereinstimmung der Ergebnisse bei verschiedenen Untersuchern/Zeitpunkten/Methoden betrug 0,496/0,411/0,215 bei der Läsionsdetektion und 0,303/0,282/0,030 bei der Läsionscharakterisierung. Schlussfolgerungen: Im ersten Jahr nach brusterhaltender Therapie erzielte die MR-Mammographie die größte diagnostische Sicherheit beim Ausschluss von Läsionen und die höchste Rate an richtig negativen Befunden. Die Beurteilung der Dignität einer nachweisbaren Läsion war mit allen Verfahren schwierig, dies zeigt sich in der generell geringen Übereinstimmung bei der Läsionscharakterisierung.

Abstract

Purpose: To compare the accuracy of lesion detection and characterization and to determine the agreement of observers, methods and timing of mammography (MX), ultrasound (US) and MR imaging (MRI) during the first year after breast conserving therapy. Materials and Methods: The study included 20 patients diagnosed with breast cancer of stages equal or inferior to T2 N1bi M0 after breast conserving therapy and subsequent radiotherapy. Patients with any history of breast diseases in the affected or contralateral breast were excluded. Patients were examined before and at 3, 6 and 12 months after adjuvant radiotherapy with MX, US and dynamic MR mammography. Additional US and MRI were performed 3 months after radiotherapy. All 220 examinations were retrospectively read in a randomized order by two independent readers, blinded for the results of the other examinations. The outcome after 2.5 years of follow-up was used as gold standard. Histological examination was available in one case. Lesion detection and specificity were assessed including kappa values for different reliabilities between observers, timing and methods. The kappa values were used to characterize the degree of agreement as follows: > 0.8 very good; 0.6 - 0.8 good; 0.4 - 0.6 fair; 0.2 - 0.4 minimal; and < 0.2 negligible. Results: Based on the interpretation of all available findings (clinical examination, MX, US, MRT and histology in one case), 20 patients observed for a mean period of 2.5 years had no evidence of intramammary recurrence. Therefore the sensitivity of the various methods could not be assessed. The reading of certainly no lesion was given by MRI in 43 %, by MX in 30 % and by US in 5 % of all examinations (p < 0.05). True negative findings were observed by MRI in 94.4 %, by MX in 90.4 % and by US in 82.5 %. Reliability between observers, timing and imaging methods was 0.496, 0.411, and 0.215 for lesion detection and 0.303, 0.282, and 0.030 for lesion characterization. Conclusion: Within the first year after breast conserving therapy, MRI was the most confident method for the exclusion of lesions and presented the highest true negative rate. The assessment of dignity of a particular lesion was difficult by all imaging methods, reflected by the weak agreement between observers, methods and timing. The difference between times of readings were marginal in the first year after therapy. Agreement between the different diagnostics methods was minimal to negligible.

Breast neoplasms - breast MR - mammography - breast ultrasound - breast conserving therapy

Literatur

• 1 Grosse A, Schreer I, Frischbier H J. et al . Results of breast conserving therapy for early breast cancer and the role of mammographic follow-up.  Int J Radiat Oncol Biol Phys. 1997;  38 761-767
• 2 Touboul E, Buffat L, Belkacemi Y. et al . Local recurrences and distant metastases after breast-conserving surgery and radiation therapy for early breast cancer.  Int J Radiat Oncol Biol Phys. 1999;  43 25-38
• 3 Veronesi U, Luini A, DelVecchio M. et al . Radiotherapy after breast-preserving surgery in women with localized cancer of the breast.  N Engl J Med. 1993;  328 1587-1591
• 4 Buchberger W, DeKoekkoek-Doll P, Obrist P. et al . Der Stellenwert der MR-Tomographie beim unklaren Mammographiebefund.  Radiologe. 1997;  37 702-709
• 5 Heywang-Köbrunner S H, Schlegel A, Beck R. et al . Contrast-enhanced MRI of the breast after limited surgery and radiation therapy.  J Comput Assist Tomogr. 1993;  17 891-900
• 6 Hitchcock Y J, Proulx G M, Stomper P C. Contrast-enhanced MRI for the assessment of local recurrence after breast conservation.  Am J Clin Oncol. 2002;  25 (4) 428-429
• 7 Kinkel K, Hylton N M. Challenges to interpretation of breast MRI.  J Magn Reson Imaging. 2001;  13 (6) 821-829
• 8 Morakkabati N, Leutner C C, Schmiedel A. et al . Breast MR Imaging in Patients during or soon after Radiotherapy (RT): How Significant are Radiation-induced Changes and Do They Interfere with Diagnostic Accuracy?.  Supplement to Radiology. 1999;  213 1524 (Abstract)
• 9 Dershaw D D. Mammography in patients with breast cancer treated by breast conservation (lumpectomy with or without radiation).  AJR Am J Roentgenol. 1995;  164 309-316
• 10 Balu-Maestro C, Bruneton J N, Geoffray A. et al . Ultrasonographic posttreatment follow-up of breast cancer patients.  J Ultrasound Med. 1991;  10 1-7
• 11 Slobodnikova J. Changes after conservative surgical treatment for early breast carcinoma: comparison of sonographic and bioptic findings.  Neoplasma. 1999;  46 179-181
• 12 Müller R D, Barkhausen J, Sauerwein W. et al . Assessment of local recurrence after breast-conserving therapy with MRI.  J Comput Assist Tomogr. 1998;  22 408-412
• 13 Wersebe A, Xydeas T, Clauß T. et al . Quantitative Erfassung von Gewebsveränderungen der Mamma nach brusterhaltender Therapie mit der dynamischen MR-Mammographie.  Fortschr Röntgenstr. 2001;  173 1109-1117
• 14 Altman D G. Inter-Rater Agreement. In: Altman DG. Practical Statistics for Medical Research London; Chapman and Hall 1991: 403-419
• 15 Drew P J, Kerin M J, Turnbull L W. et al . Routine screening for local recurrence following breast-conserving therapy for cancer with dynamic contrast-enhanced magnetic resonance imaging of the breast.  Ann Surg Oncol. 1998;  5 265-270
• 16 Jager J J, Langendijk J A, Dohmen J P. et al . Mammography in the follow-up after breast-conserving treatment in cancer of the breast: suitability for mammographic interpretation, validity and interobserver variation.  Br J Radiol. 1995;  68 754-760
• 17 Buchberger W, Hamberger L, Schön G. et al . Mammographie und Sonographie in der Rezidivdiagnostik nach brusterhaltender Therapie des Mammakarzinoms.  Fortschr Röntgenstr. 1991;  154 650-656
• 18 Aichinger U, Albert U, de Waal J. et al . Wertigkeit bildgebender Verfahren in der Diagnose Mammakarzinomrezidiv - Ergebnisse einer Multicenterstudie (1977 - 1999).  Fortschr Röntgenstr. 2001;  173 S15
• 19 Aichinger U, Schulz-Wendtland R, Krämer S. et al . Narbe oder Rezidiv? Einsatz der signalverstärkten Doppler-Sonographie im Vergleich zur MRT.  Fortschr Röntgenstr. 2002;  174 1395-1401
• 20 Krämer S, Schulz-Wendtland R, Hagedorn K. et al . Magnetic resonance imaging in the diagnosis of local recurrences in breast cancer.  Anticancer Res. 1998;  18 2159-2161
• 21 Rieber A, Merkle E, Zeitler H. et al . Value of MR mammography in the detection and exclusion of recurrent breast carcinoma.  J Comput Assist Tomogr. 1997;  21 780-784
• 22 Mumtaz H, Davidson T, Hall-Craggs M A. et al . Comparison of magnetic resonance imaging and conventional triple assessment in locally recurrent breast cancer.  Br J Surg. 1997;  84 1147-1151
• 23 Gilles R, Guinebretiere J M, Shapeero L G. et al . Assessment of breast cancer recurrence with contrast-enhanced subtraction MR imaging: preliminary results in 26 patients.  Radiology. 1993;  188 473-478
• 24 Dao T H, Rahmouni A, Campana F. et al . Tumor recurrence versus fibrosis in the irradiated breast: differentiation with dynamic gadolinium-enhanced MR imaging.  Radiology. 1993;  187 751-755
• 25 Viehweg P, Heinig A, Lampe D. et al . Retrospective analysis for evaluation of the value of contrast-enhanced MRI in patients treated with breast conservative therapy.  MAGMA. 1998;  7 141-152
• 26 Ciccone G, Vineis P, Frigerio A. et al . Inter-observer and intra-observer variability of mammogram interpretation: a field study.  Eur J Cancer. 1992;  28 1054-1058